$SINT
Sintx Technologies, Inc. Stock $sint

$sint Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017158 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$508.0K	$539.0K	$129.0K
YoY Change	111.67%	317.83%	29.0%
Cost Of Revenue	$104.0K	$118.0K	$80.00K
YoY Change	57.58%	47.5%	33.33%
Gross Profit	$404.0K	$421.0K	$49.00K
YoY Change	132.18%	759.18%	22.5%
Gross Profit Margin	79.53%	78.11%	37.98%
Selling, General & Admin	$1.476M	$1.479M	$1.250M
YoY Change	10.89%	18.32%	-3.1%
% of Gross Profit	365.35%	351.31%	2551.02%
Research & Development	$2.148M	$2.200M	$1.653M
YoY Change	45.53%	33.09%	3.31%
% of Gross Profit	531.68%	522.57%	3373.47%
Depreciation & Amortization	$222.0K	$154.0K	$69.00K
YoY Change	212.68%	123.19%	130.0%
% of Gross Profit	54.95%	36.58%	140.82%
Operating Expenses	$3.868M	$3.978M	$2.929M
YoY Change	30.81%	35.81%	1.7%
Operating Profit	-$3.464M	-$3.557M	-$2.880M
YoY Change	24.47%	23.51%	1.41%
Interest Expense	$1.012M	$4.042M	$35.00K
YoY Change	820.0%	11448.57%	-117.5%
% of Operating Profit
Other Income/Expense, Net	$1.009M	$3.264M
YoY Change	272.32%
Pretax Income	-$2.455M	-$293.0K	-$2.845M
YoY Change	-2.27%	-89.7%	8.17%
Income Tax
% Of Pretax Income
Net Earnings	-$2.455M	-$293.0K	-$2.845M
YoY Change	-2.27%	-89.7%	8.05%
Net Earnings / Revenue	-483.27%	-54.36%	-2205.43%
Basic Earnings Per Share	-$0.61	-$0.13
Diluted Earnings Per Share	-$0.78	-$0.13	-$115.1K
COMMON SHARES
Basic Shares Outstanding	4.050M shares	3.924M shares	247.1K shares
Diluted Shares Outstanding	4.437M shares	2.558M shares	247.1K shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.328M	$12.63M	$10.86M
YoY Change	20.41%	16.23%	-53.72%
Cash & Equivalents	$9.328M	$12.63M	$10.86M
Short-Term Investments
Other Short-Term Assets	$15.00K	$25.00K	$721.0K
YoY Change	-85.71%	-96.53%	-9.88%
Inventory	$883.0K	$626.0K	$299.0K
Prepaid Expenses
Receivables	$385.0K	$467.0K	$106.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.10M	$14.29M	$11.99M
YoY Change	20.29%	19.2%	-53.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.651M	$5.772M	$6.440M
YoY Change	11.13%	-10.37%	162.86%
Goodwill
YoY Change
Intangibles	$24.00K	$25.00K
YoY Change	-17.24%
Long-Term Investments
YoY Change
Other Assets	$80.00K	$84.00K	$424.0K
YoY Change	0.0%	-80.19%	-3.64%
Total Long-Term Assets	$7.998M	$8.360M	$6.894M
YoY Change	-3.24%	21.26%	135.29%
TOTAL ASSETS
Total Short-Term Assets	$11.10M	$14.29M	$11.99M
Total Long-Term Assets	$7.998M	$8.360M	$6.894M
Total Assets	$19.10M	$22.65M	$18.88M
YoY Change	9.17%	19.95%	-34.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$502.0K	$486.0K	$490.0K
YoY Change	34.95%	-0.82%	22.5%
Accrued Expenses	$1.507M	$1.504M	$1.346M
YoY Change	-2.9%	11.74%	-10.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$524.0K
YoY Change		-100.0%
Long-Term Debt Due	$94.00K	$117.0K
YoY Change	-36.49%
Total Short-Term Liabilities	$3.926M	$5.126M	$2.669M
YoY Change	31.88%	92.06%	-16.85%
LONG-TERM LIABILITIES
Long-Term Debt	$13.00K	$33.00K	$0.00
YoY Change	-96.69%		-100.0%
Other Long-Term Liabilities			$1.763M
YoY Change			28.69%
Total Long-Term Liabilities	$13.00K	$33.00K	$1.763M
YoY Change	-96.69%	-98.13%	-6.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.926M	$5.126M	$2.669M
Total Long-Term Liabilities	$13.00K	$33.00K	$1.763M
Total Liabilities	$5.286M	$6.706M	$4.432M
YoY Change	-2.92%	51.31%	-12.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$265.2M	-$262.7M
YoY Change	3.67%
Common Stock	$42.00K	$40.00K
YoY Change	-83.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.81M	$15.95M	$14.45M
YoY Change
Total Liabilities & Shareholders Equity	$19.10M	$22.65M	$18.88M
YoY Change	9.17%	19.95%	-34.18%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.455M	-$293.0K	-$2.845M
YoY Change	-2.27%	-89.7%	8.05%
Depreciation, Depletion And Amortization	$222.0K	$154.0K	$69.00K
YoY Change	212.68%	123.19%	130.0%
Cash From Operating Activities	-$3.200M	-$4.900M	-$3.180M
YoY Change	25.89%	54.09%	6.35%
INVESTING ACTIVITIES
Capital Expenditures	$98.00K	$236.0K	-$230.0K
YoY Change	-126.63%	-202.61%	21.05%
Acquisitions
YoY Change
Other Investing Activities	$0.00		$0.00
YoY Change	-100.0%		-100.0%
Cash From Investing Activities	-$98.00K	-$236.0K	-$230.0K
YoY Change	50.77%	2.61%	-156.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$11.49M
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-3.200M	-$4.900M	-3.180M
Cash From Investing Activities	-98.00K	-$236.0K	-230.0K
Cash From Financing Activities	0.000	$11.49M
Net Change In Cash	-3.298M	$6.381M	$0.00
YoY Change	5.84%		-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$3.200M	-$4.900M	-$3.180M
Capital Expenditures	$98.00K	$236.0K	-$230.0K
Free Cash Flow	-$3.298M	-$5.136M	-$2.950M
YoY Change	51.7%	74.1%	5.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001269026
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	SINT	Offering Costs Associated With Derivative Warrant Liabilities OfferingCostsAssociatedWithDerivativeWarrantLiabilities		usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	SINT	Stock Issued During Period Value Of Common Stock From Exercise Of Prefunded Warrants For Cash StockIssuedDuringPeriodValueOfCommonStockFromExerciseOfPrefundedWarrantsForCash		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q1	SINT	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q1	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q1	SINT	Right Of Use Asset For Lease Liability RightOfUseAssetForLeaseLiability		usd
CY2022Q1	SINT	Reduction Of Derivative Liability Upon Exercise Of Warrants ReductionOfDerivativeLiabilityUponExerciseOfWarrants		usd
CY2022Q1	SINT	Par Value Of Common Stock Upon Cashless Exercise Of Warrants ParValueOfCommonStockUponCashlessExerciseOfWarrants		usd
CY2022Q1	SINT	Par Value Of Common Stock Upon Exercise Of Prefunded Warrants ParValueOfCommonStockUponExerciseOfPrefundedWarrants		usd
CY2022Q1	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities		usd
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2022Q1	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-33624
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SINTX Technologies, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1375299
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1885 West 2100 South
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84119
CY2023Q1	dei	City Area Code CityAreaCode	(801)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	839-3500
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	SINT
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	33000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	368000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	6706000	usd
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4050302	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12626000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6245000	usd
CY2023Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	467000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	328000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	785000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	344000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	388000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	284000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	25000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	14291000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7209000	usd
CY2023Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	238000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	453000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5772000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5691000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2241000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2309000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	84000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	85000	usd
CY2023Q1	us-gaap	Assets Assets	22651000	usd
CY2022Q4	us-gaap	Assets Assets	15773000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	486000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	434000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1504000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1618000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	117000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	160000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2267000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5126000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	750000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	738000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5126000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8078000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1547000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1621000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10069000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4050236	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4050236	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	542145	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	542145	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	40000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	278653000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	268154000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-262748000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-262455000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	15945000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5704000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22651000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15773000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	539000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	129000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	118000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	80000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	421000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	49000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2200000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1653000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1169000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	856000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	310000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	394000	usd
CY2023Q1	SINT	Grant Expenses GrantExpenses	299000	usd
CY2022Q1	SINT	Grant Expenses GrantExpenses	26000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3978000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2929000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3557000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2880000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	2000	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	8000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	38000	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	2000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	4006000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	41000	usd
CY2023Q1	SINT	Offering Costs Associated With Derivative Warrant Liabilities OfferingCostsAssociatedWithDerivativeWarrantLiabilities	786000	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	8000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3264000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	35000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-293000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2845000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2845000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-11.51
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.74
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-11.51
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2272992	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247122	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2558059	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247122	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	17195000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	102000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2845000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14452000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5704000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5704000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	86000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4457000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	383000	usd
CY2023Q1	SINT	Adjustments To Additional Paid In Capital Extinguishment Of Derivative Liability Upon Exercise Of Warrant AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivativeLiabilityUponExerciseOfWarrant	5502000	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-2000	usd
CY2023Q1	SINT	Adjustments To Additional Paid In Capital Issuance Of Agent Warrants AdjustmentsToAdditionalPaidInCapitalIssuanceOfAgentWarrants	108000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	15945000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	15945000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2845000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	154000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	68000	usd
CY2023Q1	SINT	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	183000	usd
CY2022Q1	SINT	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	130000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	86000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	102000	usd
CY2023Q1	SINT	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	3898000	usd
CY2022Q1	SINT	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	41000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-3000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	137000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	457000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	391000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-110000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	27000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-103000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-54000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-337000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-177000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-122000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4871000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3180000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	236000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	230000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-236000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-230000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	6650000	usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	600000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4840000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	2000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11488000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6381000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3410000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6245000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14273000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12626000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10863000	usd
CY2023Q1	SINT	Right Of Use Asset For Lease Liability RightOfUseAssetForLeaseLiability	114000	usd
CY2023Q1	SINT	Reduction Of Derivative Liability Upon Exercise Of Warrants ReductionOfDerivativeLiabilityUponExerciseOfWarrants	5502000	usd
CY2023Q1	SINT	Par Value Of Common Stock Upon Cashless Exercise Of Warrants ParValueOfCommonStockUponCashlessExerciseOfWarrants	13000	usd
CY2023Q1	SINT	Par Value Of Common Stock Upon Exercise Of Prefunded Warrants ParValueOfCommonStockUponExerciseOfPrefundedWarrants	2000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	25000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	125000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	94000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	89000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	91000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	626000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	737000	usd
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 100 reverse stock split
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zEcRWcX3Qnf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zqTQNVxzgDvd">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates. As of March 31, 2023, the most significant estimate relates to derivative liabilities relating to common stock warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-300000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2800000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4900000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3200000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-262700000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-262500000	usd
CY2023Q1	us-gaap	Stockholders Equity Note Changes In Capital Structure Retroactive Impact StockholdersEquityNoteChangesInCapitalStructureRetroactiveImpact	Because the company’s public float is less than $75 million, we may not sell securities over a 12-month period in an amount greater than one-third of our public float.
CY2023Q1	us-gaap	Inventory Gross InventoryGross	400000	usd
CY2023Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	200000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1200000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2100000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2023Q1	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities	-4149000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-4442000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2272992	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	258067	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2558059	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2023Q1	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare	-1.61
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.74
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2845000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2845000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247122	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247122	shares
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-11.51
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-11.51
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	412000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	552000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2267000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5126000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	584000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	524000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	307000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	464000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	613000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	630000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1504000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1618000	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	114500000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3872	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	602
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y3M18D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	44652000	usd
CY2023Q1	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	the Company closed on a public offering of 2,150,000 units, with each unit consisting of one share of common stock, or one pre-funded warrant to purchase one share of its common stock, one Class C Warrant to purchase one share of common stock, and one half of one Class D Warrant with each whole Class D Warrant entitling the holder to purchase one share of common stock. Each unit was sold at a public offering price of $5.60. The Class C and Class D Warrants are immediately exercisable at a price of $5.60 per share. The Class C and Class D warrants each have a cashless exercise provision entitling the holders to surrender one Class C Warrant and receive 0.4 shares of common stock and on the surrender of one Class D Warrant the holder is entitled to receive 0.8 shares of common stock.
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2150000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.60
CY2022Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4656	shares
CY2022Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4700000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.70
CY2021Q1	SINT	Public Float Threshold PublicFloatThreshold	75000000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11909	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	234.02
CY2023Q1	SINT	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P6Y10M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11909	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	120.33
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	8303	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	330.56
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	9840	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	119.65
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8339	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	391
CY2022Q1	SINT	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P8Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	87553000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3570	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	49
CY2022Q1	SINT	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11909	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	238
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	11787	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	244
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y10M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	117100000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11909	shares
CY2023Q1	us-gaap	Area Of Land AreaOfLand	29534	sqft
CY2023Q1	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	This lease expires at the end of 2024. The lease has two five-year extension options.
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2200000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2300000	usd
CY2023Q1	SINT	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	200000	usd
CY2022Q1	SINT	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	100000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	654000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	897000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	269000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	190000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	131000	usd
CY2023Q1	SINT	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	539000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2680000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	383000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2297000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	750000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1547000	usd

Files In Submission

Name	View Source	Status
0001493152-23-017158-index-headers.html	Edgar Link	pending
0001493152-23-017158-index.html	Edgar Link	pending
0001493152-23-017158.txt	Edgar Link	pending
0001493152-23-017158-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sint-20230331.xsd	Edgar Link	pending
sint-20230331_cal.xml	Edgar Link	unprocessable
sint-20230331_def.xml	Edgar Link	unprocessable
sint-20230331_lab.xml	Edgar Link	unprocessable
sint-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SINT
Sintx Technologies, Inc. Stock $sint

2023 Q2 Form 10-Q Financial Statement

#000149315223017158 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT Sintx Technologies, Inc. Stock $sint

2023 Q2 Form 10-Q Financial Statement

#000149315223017158 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT
Sintx Technologies, Inc. Stock $sint